Progress in immune checkpoint inhibitor-based combined regimens in the treatment of metastatic urothelial carcinoma

Liu Jianbing; Yue Zhongjin; Shang Panfeng; Liu Yating; Chang Hong

doi:10.3969/j.issn.0253-9802.2023.09.001

Liu Jianbing, Yue Zhongjin, Shang Panfeng, Liu Yating, Chang Hong

JOURNAL OF NEW MEDICINE ›› 2023, Vol. 54 ›› Issue (9) : 611-617.

PDF(2816 KB)

JOURNAL OF NEW MEDICINE ›› 2023, Vol. 54 ›› Issue (9) : 611-617. DOI: 10.3969/j.issn.0253-9802.2023.09.001

Editorial

Progress in immune checkpoint inhibitor-based combined regimens in the treatment of metastatic urothelial carcinoma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 54(9): 611-617 https://doi.org/10.3969/j.issn.0253-9802.2023.09.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2816 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-03-07	2023-09-15
Issue Date
2023-09-27

Please choose a citation manager

Content to export